These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25860128)

  • 1. Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.
    He X; Riceberg J; Pulukuri SM; Grossman S; Shinde V; Shah P; Brownell JE; Dick L; Newcomb J; Bence N
    PLoS One; 2015; 10(4):e0123882. PubMed ID: 25860128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumoylation and Its Contribution to Cancer.
    Lee JS; Choi HJ; Baek SH
    Adv Exp Med Biol; 2017; 963():283-298. PubMed ID: 28197919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMO pathway components as possible cancer biomarkers.
    Mattoscio D; Chiocca S
    Future Oncol; 2015; 11(11):1599-610. PubMed ID: 26043214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9.
    McManus FP; Bourdeau V; Acevedo M; Lopes-Paciencia S; Mignacca L; Lamoliatte F; Rojas Pino JW; Ferbeyre G; Thibault P
    Sci Rep; 2018 May; 8(1):7754. PubMed ID: 29773808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation.
    Licciardello MP; Müllner MK; Dürnberger G; Kerzendorfer C; Boidol B; Trefzer C; Sdelci S; Berg T; Penz T; Schuster M; Bock C; Kralovics R; Superti-Furga G; Colinge J; Nijman SM; Kubicek S
    Oncogene; 2015 Jul; 34(29):3780-90. PubMed ID: 25263445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Catulin knockdown induces senescence in cancer cells.
    Fan LC; Chiang WF; Liang CH; Tsai YT; Wong TY; Chen KC; Hong TM; Chen YL
    Oncogene; 2011 Jun; 30(23):2610-21. PubMed ID: 21278790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The post-translational modification, SUMOylation, and cancer (Review).
    Han ZJ; Feng YH; Gu BH; Li YM; Chen H
    Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
    Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
    Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice.
    Nacerddine K; Lehembre F; Bhaumik M; Artus J; Cohen-Tannoudji M; Babinet C; Pandolfi PP; Dejean A
    Dev Cell; 2005 Dec; 9(6):769-79. PubMed ID: 16326389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMOylation in carcinogenesis.
    Bettermann K; Benesch M; Weis S; Haybaeck J
    Cancer Lett; 2012 Mar; 316(2):113-25. PubMed ID: 22138131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Sumoylation in Senescence.
    Scurr LL; Haferkamp S; Rizos H
    Adv Exp Med Biol; 2017; 963():215-226. PubMed ID: 28197915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles for SUMO modification during senescence.
    Andreou AM; Tavernarakis N
    Adv Exp Med Biol; 2010; 694():160-71. PubMed ID: 20886763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SUMO-specific protease SENP5 is required for cell division.
    Di Bacco A; Ouyang J; Lee HY; Catic A; Ploegh H; Gill G
    Mol Cell Biol; 2006 Jun; 26(12):4489-98. PubMed ID: 16738315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO targets the APC/C to regulate transition from metaphase to anaphase.
    Eifler K; Cuijpers SAG; Willemstein E; Raaijmakers JA; El Atmioui D; Ovaa H; Medema RH; Vertegaal ACO
    Nat Commun; 2018 Mar; 9(1):1119. PubMed ID: 29549242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sumoylation at chromatin governs coordinated repression of a transcriptional program essential for cell growth and proliferation.
    Neyret-Kahn H; Benhamed M; Ye T; Le Gras S; Cossec JC; Lapaquette P; Bischof O; Ouspenskaia M; Dasso M; Seeler J; Davidson I; Dejean A
    Genome Res; 2013 Oct; 23(10):1563-79. PubMed ID: 23893515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
    J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia regulates sumoylation pathways in intervertebral disc cells: implications for hypoxic adaptations.
    Wang F; Cai F; Shi R; Wei JN; Wu XT
    Osteoarthritis Cartilage; 2016 Jun; 24(6):1113-24. PubMed ID: 26826302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific up-regulation of p21 by a small active RNA sequence suppresses human colorectal cancer growth.
    Wang LL; Guo HH; Zhan Y; Feng CL; Huang S; Han YX; Zheng WS; Jiang JD
    Oncotarget; 2017 Apr; 8(15):25055-25065. PubMed ID: 28445988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.
    He X; Riceberg J; Soucy T; Koenig E; Minissale J; Gallery M; Bernard H; Yang X; Liao H; Rabino C; Shah P; Xega K; Yan ZH; Sintchak M; Bradley J; Xu H; Duffey M; England D; Mizutani H; Hu Z; Guo J; Chau R; Dick LR; Brownell JE; Newcomb J; Langston S; Lightcap ES; Bence N; Pulukuri SM
    Nat Chem Biol; 2017 Nov; 13(11):1164-1171. PubMed ID: 28892090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting SUMO Signaling to Wrestle Cancer.
    Kroonen JS; Vertegaal ACO
    Trends Cancer; 2021 Jun; 7(6):496-510. PubMed ID: 33353838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.